Introduction: Eribroma oblongum (Malvaceae) stem bark is used in Cameroonian ethnomedicine to treat various metabolic illnesses including cardiovascular diseases. The present study was designed to investigate the mechanisms of hypotensive effects of hydroethanolic extract of Eribroma oblongum and its cardioprotective effects after a subchronic treatment. Study Design: This was a prospective cross-sectional analytical study Methodology: Preventive effects were studied after oral administration of hydroethanolic extract of Eribroma oblongum (HEEO) (100 mg/kg body weight/day) or captopril (25 mg/kg body weight/day) simultaneously with L-NAME (40 mg/kg body weight/ day) in rats for 28 days. Body weight and food intake were measured after 5 days. At the end of treatment, blood pressure and heart rate were recorded. Aorta, heart, liver and kidneys were weighted. Reduced nitrite, superoxide dismutase, catalase, gluthatione, Malondialdehyde and lipid profile were measured. Results: The extract prevented L-NAME hypertension and improved food intake and body weight of rats. HEEO improved lipid profile and antioxidant status. L-NAME caused a significant (P<0.001) increase in the levels of serum transaminase relative to the normal. L-NAME treated rats had markedly decreased catalase (CAT), superoxide dismutase (SOD), nitrite (NO2-) and reduced glutathione (GSH) levels in the tissue. Also, L-NAME caused a significant (P<0.001) induction of lipid peroxidation (MDA) in the animals tissue relative to the normal range. Administration of HEEO with L- NAME caused significant (P<0.001) inhibition of MDA relative to LNHR and augmented tissue antioxidant indices. Conclusion: The hydroethanolic stem bark extract of Eribroma oblongum showed a promising potential cardioprotective effect in L-NAME induced hypertension. This effect could be due at least in part by improving endothelial function, lipid profile and oxidative status. These findings justify the traditional use of HEEO as treatment in cardiovascular disorders and serve as a promising traditional pharmacopoeia for the development of new chemical entity in the phytomedicine development platform.
Published in | Journal of Diseases and Medicinal Plants (Volume 2, Issue 4) |
DOI | 10.11648/j.jdmp.20160204.11 |
Page(s) | 43-50 |
Creative Commons |
This is an Open Access article, distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium or format, provided the original work is properly cited. |
Copyright |
Copyright © The Author(s), 2016. Published by Science Publishing Group |
Eribroma oblongum, L-NAME, Blood Pressure, NO, Antihypertensive and Antioxidant Activities, Wistar Rat
[1] | Beevers G, Lip GY, O'Brien E: ABC of hypertension: The pathophysiology of hypertension. BMJ (Clin Res ed) 2001, 322(7291): 912-916. |
[2] | Razny U, Kiec-Wilk B, Wator L, Polus A, Dyduch G, Solnica B, Malecki M, Tomaszewska R, Cooke JP, Dembinska-Kiec A: Increased nitric oxide availability attenuates high fat diet metabolic alterations and gene expression associated with insulin resistance. Cardiovasc Diabetol 2011; 10: 68. |
[3] | WHO. World health report. Reducing risks, promoting healthy life, World Health Organization, Geneva, Switzerland 2002; 7-14. |
[4] | Whitworth, JA. World Health Organization, International Society of Hypertension Writing Group. World Heath Organization (WHO)/InternationalSociety of Hypertension (ISH) statement on management of hypertension. Journal of Hypertension 2003; 11: 1983–1992. |
[5] | OMS (Organisation Mondiale de la Santé). Médicine traditionnelle. Aide mémoire No 134. Geneva: WHO; 2003; 4. |
[6] | Tsague MV, Fokunang NC, Ngameni B, Tembe-fokunang EA, Guedje NM, Ngo Lemba Tom E, Atogho-Tiedeu B, Zintchem RF, Mecthi Dongmo M, Ngoupayo J, Sokeng S, Dzeufiet Djomeni, Oben JE, Dimo T, Ze Minkande J and Ngadjui Tchaleu B. Pre-clinical evaluation of the hypotensive and anti atherogenic activity of hydroethanolic extract of Eribroma oblongum (Malvaceae) stem bark on wistar rats models. British Journal of Pharmaceutical research. 2015; 5(1): 1-14 |
[7] | EEC: Council Directive 86/609/EEC of 24 November 1986 on the approximation of laws, regulations and administrative provisions of the Member States regarding the protection of animals used for experimental and other scientific purposes. Official Journal of the European Communities1986; L358:1–29. |
[8] | Dimo T, Nguelefack TB, Tan PV, Yewah MP, Dongo E, Rakotonirina SV, Kamanyi A and Bopelet M. Possible mechanisms of action of the neutral extract from Biden spilosa L. leaves on the cardiovascular system of anesthetized rats. Phytother Res 2003; 17: 1135–1139. |
[9] | Ester Ngo Lemba Tom, Céline Demougeot, Orelien Bopda Mtopi, Théophile Dimo, Paul Désiré Dzeufiet Djomeni, Danielle Claude Bilanda, Corinne Girard, Alain Berthelot. Journal of etnopharmacology 133 (2011); 828-833. |
[10] | Misra H, Fridovich I. The role of superoxide anion in the autoxidation of epinephrine to adrenochrome and a simple assay for superoxide dismutase.Journal of Biological Chemistry 1972; 247:3170–5. |
[11] | Sinha AK. Colorimetric assay of catalase. Analytical Biochemistry 1972; 47:389–94. |
[12] | Ellman GL. Tissue sulfhydryl group. Archives of Biochemistry and Biophysics 1959; 82:70–7. |
[13] | Ikeda U., M. Takahashi and K. Shimada. C-reactive protein directly inhibits nitric oxide production by cytokine-stimulated vascular smooth muscle cells. J. Cardiovasc. Pharmacol., 2003; 42: 607-611. |
[14] | Wilbur KM, Bergheim F, Shapiro OW. Determination of lipid peroxidation. Archives of Biochemistry 1949; 24: 305–10. |
[15] | Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clinical Chemistry 1972; 18:499–502. |
[16] | Corvol P. L’endothélium, plaque tournante de la vasomotricité et de la trophicité de la paroi artérielle. Médecine/Sciences. 1993; 9(10):1031-1033. |
[17] | Badyal DK, Lata H, Dadhich AP. Animal models of hypertension and effect of drugs. Indien Journal of Pharmacology, 35:349-362.ms in cardiology. 2003; 28: 137-155. |
[18] | Saravanakumar M, Raja B. Effect of veratric acid on the cardiovascular risk of L-NAME-induced hypertensive rats. Journal of Cardiovascular Pharmacology. 2012; 59: 553-562. |
[19] | Deshmukh M, Lee HW, McFarlane SI, Whaley-Connell A. Antihypertensive medications and their effects on lipid metabolism. Curr Diab Rep. 2008; 3: 24-220. |
[20] | Han LK, Zheng YN, Xu BJ, Okuda H, Kimura Y. Saponins from platycodi radix ameliorate high fat diet-induced obesity in mice. J Nutr. 2002; 132(8): 2241-2245. |
[21] | Hilaly J, El Israili ZH, Lyoussi B. Acute and chronic toxicological studies of Ajuga ivain experimental animals. Journal of Ethnopharmacology. 2004; 91: 43-50. |
[22] | Kudo T, Tamagawa T, Shibata S. Effect of chronic ethanol exposure on the liver of Clock-mutant mice. J Circadian Rhythms 2009; 10.1186/1740-3391-7-4. |
[23] | Tsuchiya K, Shuhei T, Keisuke I, Shinji A, Yasumasa I, Yoshitaka K, et al. Dietary nitrite ameliorates renal injury in l-NAME-induced hypertensiverats. Nitric Oxide 2009;22:98–103. |
[24] | Kang DG, Hur TY, Lee GM, Oh H, Kwon TO, Sohn EJ, et al. Effects of Cudrania tricuspidata water extract on blood pressure and renal functions in NO-dependent hypertension. Life Sciences 2002;70:2599–609. |
[25] | Miguel-Carrasco JL, Monserrat MT, Mate A, Vázquez CM. Comparative effects of captopril and l-carnitine on blood pressure and antioxidant enzyme gene expression in the heart of spontaneously hypertensive rats. European Journal of Pharmacology 2010;632:65–72. |
[26] | Jover B, Mimran A. Nitric oxid inhibition and renal alterations. J. cardiovasc Pharmacol.2001; 38(2):65-70. |
[27] | José Marcos Girardi, Rogério Estevan Farias, Ana Paula Ferreira, and Nádia Rezende Barbosa Raposo. Rosuvastatin prevents proteinuria and renal inflammation in nitric oxide–deficient rats. Clinics (Sao Paulo). 2011; 66(8): 1457–1462. |
[28] | Scheuer H, Gwinner W, Hohbach J, Gröne EF, Brandes RP, Malle E, Olbricht CJ, Walli AK, Gröne HJ. Oxidant stress in hyperlipidemia induced renal damage. Am J Physiol Renal Physiol. 2000; 278: F63-F74. |
[29] | Rodrigo R, Prat H, Passalacqua W, Araya J, Guichard C, Bachlet JP. Relationship between Oxidative Stress and Essential Hypertension. Hypertension Research. 2007; 30 : 1159-1167. |
[30] | Stein HJ, Esplugues J, Whittle BJR. Direct cytotoxic effect of oxygen free radicals on the gastric mucosa. Surgery. 1989; 106: 318-24. |
[31] | Faraci FM, Didion SP. Vascular protection: superoxide dismutase isoforms in the vessel wall. Artheriosclerosis Thrombose and Vascular Biology. 2004; 24: 1367-1373. |
[32] | El Midaoui A, de Champlain J. Prevention of hypertension, insulin resistance, and oxidative stress by α-Lipoic acid. Hypertension. 2002; 39: 303-307. |
[33] | Nayeemunisa, Kumda MR. Cardioprotective effects of Cichorium intybus in ageing myocardium of albino rats. Current Science. 2003; 84: 94-943. |
APA Style
Tsague Marthe Valentine, Fokunang N. Charles, Tembe Achick Estella, Mvondo Anne Mauricette, Afane Ela Anatole, et al. (2016). Hydroethanolic Extract of Eribroma oblongum (Malvaceae) Stem Bark Prevents Hypertension, Oxidative Stress and Dyslipidemia in L-NAME Induced Hypertension in Wistar Rats. Journal of Diseases and Medicinal Plants, 2(4), 43-50. https://doi.org/10.11648/j.jdmp.20160204.11
ACS Style
Tsague Marthe Valentine; Fokunang N. Charles; Tembe Achick Estella; Mvondo Anne Mauricette; Afane Ela Anatole, et al. Hydroethanolic Extract of Eribroma oblongum (Malvaceae) Stem Bark Prevents Hypertension, Oxidative Stress and Dyslipidemia in L-NAME Induced Hypertension in Wistar Rats. J. Dis. Med. Plants 2016, 2(4), 43-50. doi: 10.11648/j.jdmp.20160204.11
AMA Style
Tsague Marthe Valentine, Fokunang N. Charles, Tembe Achick Estella, Mvondo Anne Mauricette, Afane Ela Anatole, et al. Hydroethanolic Extract of Eribroma oblongum (Malvaceae) Stem Bark Prevents Hypertension, Oxidative Stress and Dyslipidemia in L-NAME Induced Hypertension in Wistar Rats. J Dis Med Plants. 2016;2(4):43-50. doi: 10.11648/j.jdmp.20160204.11
@article{10.11648/j.jdmp.20160204.11, author = {Tsague Marthe Valentine and Fokunang N. Charles and Tembe Achick Estella and Mvondo Anne Mauricette and Afane Ela Anatole and Oben E. Julius and Ngadjui Tchaleu Bonaventure and Ntchapda Fidèle and Sokeng Dongmo Sélestin and Nyangono Biyegue Christine Fernande and Dimo Théophile and Ze Minkande Jacqueline}, title = {Hydroethanolic Extract of Eribroma oblongum (Malvaceae) Stem Bark Prevents Hypertension, Oxidative Stress and Dyslipidemia in L-NAME Induced Hypertension in Wistar Rats}, journal = {Journal of Diseases and Medicinal Plants}, volume = {2}, number = {4}, pages = {43-50}, doi = {10.11648/j.jdmp.20160204.11}, url = {https://doi.org/10.11648/j.jdmp.20160204.11}, eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.jdmp.20160204.11}, abstract = {Introduction: Eribroma oblongum (Malvaceae) stem bark is used in Cameroonian ethnomedicine to treat various metabolic illnesses including cardiovascular diseases. The present study was designed to investigate the mechanisms of hypotensive effects of hydroethanolic extract of Eribroma oblongum and its cardioprotective effects after a subchronic treatment. Study Design: This was a prospective cross-sectional analytical study Methodology: Preventive effects were studied after oral administration of hydroethanolic extract of Eribroma oblongum (HEEO) (100 mg/kg body weight/day) or captopril (25 mg/kg body weight/day) simultaneously with L-NAME (40 mg/kg body weight/ day) in rats for 28 days. Body weight and food intake were measured after 5 days. At the end of treatment, blood pressure and heart rate were recorded. Aorta, heart, liver and kidneys were weighted. Reduced nitrite, superoxide dismutase, catalase, gluthatione, Malondialdehyde and lipid profile were measured. Results: The extract prevented L-NAME hypertension and improved food intake and body weight of rats. HEEO improved lipid profile and antioxidant status. L-NAME caused a significant (P<0.001) increase in the levels of serum transaminase relative to the normal. L-NAME treated rats had markedly decreased catalase (CAT), superoxide dismutase (SOD), nitrite (NO2-) and reduced glutathione (GSH) levels in the tissue. Also, L-NAME caused a significant (P<0.001) induction of lipid peroxidation (MDA) in the animals tissue relative to the normal range. Administration of HEEO with L- NAME caused significant (P<0.001) inhibition of MDA relative to LNHR and augmented tissue antioxidant indices. Conclusion: The hydroethanolic stem bark extract of Eribroma oblongum showed a promising potential cardioprotective effect in L-NAME induced hypertension. This effect could be due at least in part by improving endothelial function, lipid profile and oxidative status. These findings justify the traditional use of HEEO as treatment in cardiovascular disorders and serve as a promising traditional pharmacopoeia for the development of new chemical entity in the phytomedicine development platform.}, year = {2016} }
TY - JOUR T1 - Hydroethanolic Extract of Eribroma oblongum (Malvaceae) Stem Bark Prevents Hypertension, Oxidative Stress and Dyslipidemia in L-NAME Induced Hypertension in Wistar Rats AU - Tsague Marthe Valentine AU - Fokunang N. Charles AU - Tembe Achick Estella AU - Mvondo Anne Mauricette AU - Afane Ela Anatole AU - Oben E. Julius AU - Ngadjui Tchaleu Bonaventure AU - Ntchapda Fidèle AU - Sokeng Dongmo Sélestin AU - Nyangono Biyegue Christine Fernande AU - Dimo Théophile AU - Ze Minkande Jacqueline Y1 - 2016/06/16 PY - 2016 N1 - https://doi.org/10.11648/j.jdmp.20160204.11 DO - 10.11648/j.jdmp.20160204.11 T2 - Journal of Diseases and Medicinal Plants JF - Journal of Diseases and Medicinal Plants JO - Journal of Diseases and Medicinal Plants SP - 43 EP - 50 PB - Science Publishing Group SN - 2469-8210 UR - https://doi.org/10.11648/j.jdmp.20160204.11 AB - Introduction: Eribroma oblongum (Malvaceae) stem bark is used in Cameroonian ethnomedicine to treat various metabolic illnesses including cardiovascular diseases. The present study was designed to investigate the mechanisms of hypotensive effects of hydroethanolic extract of Eribroma oblongum and its cardioprotective effects after a subchronic treatment. Study Design: This was a prospective cross-sectional analytical study Methodology: Preventive effects were studied after oral administration of hydroethanolic extract of Eribroma oblongum (HEEO) (100 mg/kg body weight/day) or captopril (25 mg/kg body weight/day) simultaneously with L-NAME (40 mg/kg body weight/ day) in rats for 28 days. Body weight and food intake were measured after 5 days. At the end of treatment, blood pressure and heart rate were recorded. Aorta, heart, liver and kidneys were weighted. Reduced nitrite, superoxide dismutase, catalase, gluthatione, Malondialdehyde and lipid profile were measured. Results: The extract prevented L-NAME hypertension and improved food intake and body weight of rats. HEEO improved lipid profile and antioxidant status. L-NAME caused a significant (P<0.001) increase in the levels of serum transaminase relative to the normal. L-NAME treated rats had markedly decreased catalase (CAT), superoxide dismutase (SOD), nitrite (NO2-) and reduced glutathione (GSH) levels in the tissue. Also, L-NAME caused a significant (P<0.001) induction of lipid peroxidation (MDA) in the animals tissue relative to the normal range. Administration of HEEO with L- NAME caused significant (P<0.001) inhibition of MDA relative to LNHR and augmented tissue antioxidant indices. Conclusion: The hydroethanolic stem bark extract of Eribroma oblongum showed a promising potential cardioprotective effect in L-NAME induced hypertension. This effect could be due at least in part by improving endothelial function, lipid profile and oxidative status. These findings justify the traditional use of HEEO as treatment in cardiovascular disorders and serve as a promising traditional pharmacopoeia for the development of new chemical entity in the phytomedicine development platform. VL - 2 IS - 4 ER -